These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7932546)

  • 61. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
    Sperka T; Pitlik J; Bagossi P; Tözsér J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3086-90. PubMed ID: 15893929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
    Perez MA; Fernandes PA; Ramos MJ
    J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
    Nalam MN; Ali A; Altman MD; Reddy GS; Chellappan S; Kairys V; Ozen A; Cao H; Gilson MK; Tidor B; Rana TM; Schiffer CA
    J Virol; 2010 May; 84(10):5368-78. PubMed ID: 20237088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease.
    Li D; Liu MS; Ji B; Hwang KC; Huang Y
    Chem Biol Drug Des; 2012 Sep; 80(3):440-54. PubMed ID: 22621379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-peptidic HIV protease inhibitors.
    Chrusciel RA; Strohbach JW
    Curr Top Med Chem; 2004; 4(10):1097-114. PubMed ID: 15193141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How flexible is tipranavir in complex with the HIV-1 protease active site?
    Schake D
    AIDS; 2004 Feb; 18(3):579-80. PubMed ID: 15090819
    [No Abstract]   [Full Text] [Related]  

  • 67. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V; Berti F; Benedetti F; Miertus S
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determination of the relative binding free energies of peptide inhibitors to the HIV-1 protease.
    Ferguson DM; Radmer RJ; Kollman PA
    J Med Chem; 1991 Aug; 34(8):2654-9. PubMed ID: 1652028
    [No Abstract]   [Full Text] [Related]  

  • 69. Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.
    Jadhav PK; Woerner FJ; Lam PY; Hodge CN; Eyermann CJ; Man HW; Daneker WF; Bacheler LT; Rayner MM; Meek JL; Erickson-Viitanen S; Jackson DA; Calabrese JC; Schadt M; Chang CH
    J Med Chem; 1998 Apr; 41(9):1446-55. PubMed ID: 9554878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationships.
    Romines KR; Morris JK; Howe WJ; Tomich PK; Horng MM; Chong KT; Hinshaw RR; Anderson DJ; Strohbach JW; Turner SR; Mizsak SA
    J Med Chem; 1996 Sep; 39(20):4125-30. PubMed ID: 8831779
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The not-so-great escape.
    Erickson JW
    Nat Struct Biol; 1995 Jul; 2(7):523-9. PubMed ID: 7664118
    [No Abstract]   [Full Text] [Related]  

  • 73. Dimeric 4-Aryl-1,4-dihydropyridines: development of a third class of nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A
    Mini Rev Med Chem; 2002 Jun; 2(3):235-45. PubMed ID: 12370065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and HIV protease inhibitory activity of new 4-hydroxy-2-pyrone derivatives.
    Lee YS; Kim SN; Lee YS; Lee JY; Lee CK; Kim HS; Park H
    Arch Pharm (Weinheim); 2000 Oct; 333(10):319-22. PubMed ID: 11092133
    [No Abstract]   [Full Text] [Related]  

  • 75. PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides.
    Frenkel D; Clark DE; Li J; Murray CW; RObson B; Waszkowycz B; Westhead DR
    J Comput Aided Mol Des; 1995 Jun; 9(3):213-25. PubMed ID: 7561974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors.
    Islam I; Ng KY; Chong KT; McQuade TJ; Hui JO; Wilkinson KF; Rush BD; Ruwart MJ; Borchardt RT; Fisher JF
    J Med Chem; 1994 Jan; 37(2):293-304. PubMed ID: 8295217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of the three-dimensional structures of protein target molecules in structure-based drug design.
    Greer J; Erickson JW; Baldwin JJ; Varney MD
    J Med Chem; 1994 Apr; 37(8):1035-54. PubMed ID: 8164249
    [No Abstract]   [Full Text] [Related]  

  • 78. Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases.
    Yan YL; Cohen SM
    Org Lett; 2007 Jun; 9(13):2517-20. PubMed ID: 17521196
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Convenient replacement of the hydroxy by an amino group in 4 hydroxycoumarin and 4-hydroxy-6-methyl-2-pyrone under microwave irradiation.
    Stoyanov EV; Ivanov IC
    Molecules; 2004 Jul; 9(8):627-31. PubMed ID: 18007464
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes.
    Rich DH; Sun CQ; Vara Prasad JV; Pathiasseril A; Toth MV; Marshall GR; Clare M; Mueller RA; Houseman K
    J Med Chem; 1991 Mar; 34(3):1222-5. PubMed ID: 2002464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.